Golden JW - Search Results

1

Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.

Brocato RL, Principe LM, Kim RK, Zeng X, Williams JA, Liu Y, Li R, Smith JM, Golden JW, Gangemi D, Youssef S, Wang Z, Glanville J, Hooper JW. Brocato RL, et al. Among authors: golden jw. J Virol. 2020 Oct 27;94(22):e01683-20. doi: 10.1128/JVI.01683-20. Print 2020 Oct 27. J Virol. 2020. PMID: 32900822 Free PMC article.

2

Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.

Hooper JW, Golden JW, Ferro AM, King AD. Hooper JW, et al. Among authors: golden jw. Vaccine. 2007 Feb 26;25(10):1814-23. doi: 10.1016/j.vaccine.2006.11.017. Epub 2006 Nov 27. Vaccine. 2007. PMID: 17240007 Free PMC article.

3

Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein.

Su HP, Golden JW, Gittis AG, Hooper JW, Garboczi DN. Su HP, et al. Among authors: golden jw. Virology. 2007 Nov 25;368(2):331-41. doi: 10.1016/j.virol.2007.06.042. Epub 2007 Aug 3. Virology. 2007. PMID: 17688903 Free PMC article.

4

Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.

Golden JW, Hooper JW. Golden JW, et al. Virology. 2008 Jul 20;377(1):19-29. doi: 10.1016/j.virol.2008.04.003. Epub 2008 May 14. Virology. 2008. PMID: 18482742 Free PMC article.

5

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.

Golden JW, Josleyn MD, Hooper JW. Golden JW, et al. Vaccine. 2008 Jun 25;26(27-28):3507-15. doi: 10.1016/j.vaccine.2008.04.017. Epub 2008 Apr 28. Vaccine. 2008. PMID: 18485547

6

Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.

Hooper JW, Ferro AM, Golden JW, Silvera P, Dudek J, Alterson K, Custer M, Rivers B, Morris J, Owens G, Smith JF, Kamrud KI. Hooper JW, et al. Among authors: golden jw. Vaccine. 2009 Dec 11;28(2):494-511. doi: 10.1016/j.vaccine.2009.09.133. Epub 2009 Oct 13. Vaccine. 2009. PMID: 19833247 Free PMC article.

7

Evaluating the orthopoxvirus type I interferon-binding molecule as a vaccine target in the vaccinia virus intranasal murine challenge model.

Golden JW, Hooper JW. Golden JW, et al. Clin Vaccine Immunol. 2010 Nov;17(11):1656-65. doi: 10.1128/CVI.00235-10. Epub 2010 Sep 15. Clin Vaccine Immunol. 2010. PMID: 20844086 Free PMC article.

8

The strategic use of novel smallpox vaccines in the post-eradication world.

Golden JW, Hooper JW. Golden JW, et al. Expert Rev Vaccines. 2011 Jul;10(7):1021-35. doi: 10.1586/erv.11.46. Expert Rev Vaccines. 2011. PMID: 21806397 Free PMC article. Review.

9

Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.

Golden JW, Zaitseva M, Kapnick S, Fisher RW, Mikolajczyk MG, Ballantyne J, Golding H, Hooper JW. Golden JW, et al. Virol J. 2011 Sep 20;8:441. doi: 10.1186/1743-422X-8-441. Virol J. 2011. PMID: 21933385 Free PMC article.

10

Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates.

Golden JW, Josleyn M, Mucker EM, Hung CF, Loudon PT, Wu TC, Hooper JW. Golden JW, et al. PLoS One. 2012;7(7):e42353. doi: 10.1371/journal.pone.0042353. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22860117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page